Covered recipient · General Payments record
VINCENT J MARINO
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$2,740.78
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,556.97 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Sight Sciences, Inc. | $250.27 | 2 |
| Alcon Laboratories Inc | $187.54 | 4 |
| Sandoz Inc. | $144.80 | 1 |
| Harrow Eye, LLC | $125.00 | 1 |
| ABBVIE INC. | $124.98 | 1 |
| Astellas Pharma US Inc | $124.22 | 1 |
| Rayner Intraocular Lenses Limited | $123.67 | 1 |
| ANI Pharmaceuticals, Inc. | $123.06 | 1 |
| Axsome Therapeutics, Inc. | $121.16 | 1 |
| Amgen Inc. | $119.98 | 1 |
| BIOTISSUE HOLDINGS INC. | $112.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $124.98 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104967296 | CMS |
| Alcon Vision LLC | $106.29 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110677159 | CMS |
| Alcon Vision LLC | $26.61 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110677155 | CMS |
| Alcon Vision LLC | $23.27 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110677153 | CMS |
| Alcon Vision LLC | $31.37 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110677157 | CMS |
| Amgen Inc. | $119.98 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115903606 | CMS |
| ANI Pharmaceuticals, Inc. | $123.06 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091167232 | CMS |
| Astellas Pharma US Inc | $124.22 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139429162 | CMS |
| Axsome Therapeutics, Inc. | $121.16 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148327345 | CMS |
| BIOTISSUE HOLDINGS INC. | $112.29 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148775803 | CMS |
| Harrow Eye, LLC | $125.00 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145609046 | CMS |
| Rayner Intraocular Lenses Limited | $123.67 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1076274212 | CMS |
| Sandoz Inc. | $144.80 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089364025 | CMS |
| Sight Sciences, Inc. | $120.61 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151934097 | CMS |
| Sight Sciences, Inc. | $129.66 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151934099 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.